Gastric ECL-Cell Hyperplasia and Carcinoids in Rodents Following Chronic Administration of H 2 -Antagonists SK&F 93479 and Oxmetidine and Omeprazole

Abstract

The histamine H₂-receptor antagonist SK&F 93479 induced gastric neuroendocrine (carcinoid) ECL-cell tumor formation in 6/34 male and 8/37 female rats treated for 22-24 months at 1,000 mg/kg/day po. Focal ECL-cell hyperplasia was present in 21/34 males and 15/37 females, with local infiltration through the muscularis mucosae in half these cases. No focal hyperplasias or carcinoids were present after 200 mg/kg/day po treatment. Investigative studies showed evidence for marked and sustained hypergastrinemia increasing on chronic dosing which was capable of restoring gastric acid secretion and pH to near control values. Using morphometric analysis of immunoperoxidase anti-chromogranin A stained sections, a dose-related and time-dependent neuroendocrine ECL-cell hyperplasia was correlated with the sustained elevated hypergastrinemia. A 21-month mouse oncogenicity study showed no focal neuroendocrine cell hyperplasia or carcinoid tumor induction, but a diffuse neuroendocrine cell hyperplasia and an increase in multifocal glandular hyperplasia of the oxyntic mucosa was observed in mice treated with 1,000 mg/kg SK&F 93479 po. The morphological changes observed in both rat and mouse were considered to be secondary to the hypergastrinemia resulting from the pharmacological suppression of gastric acid secretion by SK&F 93479. These changes were also observed to a more marked degree following omeprazole treatment and were only slight following oxmetidine treatment in the rat.

References

1. Betton GR and Salmon GK (1986). Neuroendocrine (carcinoid) tumours of the glandular stomach of the rat following treatment with the H2-receptor antagonist SK&F 93479. Arch. Toxicol. Suppl. 9: 471.

2. Bordi C , Cocconi G , Togni R , Vezzadini P , and Missale G (1974). Gastric endocrine cell proliferation: Association with Zollinger-Ellison syndrome. Arch. Path. 98: 274–278.

3. Brittain RT , Jack D , Reeves JJ , and Stables R (1985). Pharmacological basis for the induction of gastric carcinoid tumours in the rat by loxtidine, an unsur-mountable histamine H2-receptor blocking drug. Brit. J. Pharmacol. 85: 834–847.

4. Borch K , Renvall H , Liedberg G , and Anderson BN (1986). Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand. J. Gastroenterol. 21: 357–363.

5. Eckman L , Hansson E , Havu N , Carlsson E , and Lundberg C (1985). Toxicological studies on omeprazole. Scand. J. Gastroenterol. (Suppl. 108) 20: 53–69.

6. Harvey RF , Bradshaw MJ , Davidson CM , Wilkinson SP , and Davies PS (1985). Multifocal gastric carcinoid tumors, achlorhydria and hypergastrinaemia. Lancet ii: 951–954.

7. Harleman JH , Betton GR , Dormer CS , and McCrossan M (1987). Gastric neuroendocrine cell hyperplasia after treatment with the long-acting potent H2-receptor antagonist SK&F 93479. Scand. J. Gastroenterol. 22: 595–600.

8. Hirth RS (1988). ECL cell proliferation and neoplasia associated with the H2-receptor antagonist, BL-6341. Toxicol. Pathol. 16 (in press).

9. Ithell KL , Jackson B , Maguire JP , Smith R , and Underwood AH (1985). SK&F 93479 raises plasma gas trin and gastric mucosal histidine decarboxylase in the rat. Regul. Peptides 13: 75.

10.

10. Kishimoto S , Kunita S , Shimizu S , Koh H , Yamamoto M , Kajiyama G , and Miyoshi A (1983). Effects of atrophic changes in mucosa and endogenous gastrin (hypergastrinaemia) on development of experimental gastric cancer and its growth in rats: A pilot study. Hiroshima J. Med. Sci. 32: 213–218.

11.

11. Moses RE , Grank BB , Leavitt M , and Miller R (1986). The syndrome of Type A chronic atrophic gastritis, pernicious anaemia and multiple gastric carcinoids. J. Clin. Gastroenterol. 8: 61–65.

12.

12. Penston J and Wormsley KG (1987). Achlorhydria: hypergastrinaemia: carcinoids–-A flawed hypothesis? Gut 28: 488–505.

13.

13. Poynter P , Pick CR , Harcourt RA , Selway SAM , Ainge G , Harman IW , Spurling NW , Fluck PA , and Cook JL (1985). Association of long lasting unsurmountable histamine H2-blockade and gastric carcinoid tumours in the rat. Gut 26: 1284–1295.

14.

14. Poynter D , Selway SAM , Papworth SA , and Riches SR (1986). Changes in the gastric mucosa of the mouse associated with long-lasting unsurmountable histamine H2-blockade. Gut 27: 1338–1346.

15.

15. Saito T (1986). Experimental carcinogenesis. In: Gastric Carcinoma, MI Filipe and JR Jass (eds). Churchill Livingstone, Edinburgh, pp. 20–44.

16.

16. Streett CS , Cimprich RE , and Robertson JL (1984). Pathologic findings of the stomachs of rats treated with the H2-receptor antagonist tiotidine. Scand. J. Gastroenterol. (Suppl. 101) 19: 109–117.

17.

17. Streett CS , Robertson JL , and Crissman JW (1987). Morphologic stomach findings in rats and mice treated with H2-receptor antagonists ICI 125,211 and ICI 162,846. Toxicol. Pathol. 15: 364–365 (Abstract).

18.

18. Sundler F , Hakanson R , Carlsson E , Larsson H , and Mattsson H (1985). Hypergastrinaemia after blockade of acid secretion in the rat: Trophic effects. Digestion (Suppl. 1) 35: 56–59.

19.

19. Tahara E , Ito H , Nakagami K , and Shimamoto F (1981). Induction of carcinoids in the glandular stomach of rats by N-methyl-N'-nitro-N-nitrosoguanidine. J. Cancer Res. Clin. Onco. 100: 1–12.

20.

20. Tatsuta M , Yamamura H , Taniguchi H , and Tamura H (1982). Gastrin protection against chemically induced gastric adenocarcinomas in Wistar rats: Histopathology of the glandular stomach and incidence of gastric adenocarcinoma. J. Natl. Cancer Inst. 69: 59–66.

21.

21. Tielemans Y , Sundler F , Hakanson R , and Williams G (1987). Omeprazole stimulates ECL cell replication in the rat. Proc. Amer. Gastroenterol. Ass. pA 153 (Abstract).

22.

22. Wells T and Harleman JH (1988). Measurement of rat plasma gastrin using a small volume adaptation of the Becton Dickinson Kit. J. Appl. Toxicol. (in press).

23.

23. Yasui W and Tahara E (1985). Effect of gastrin on gastrin mucosal cyclic adenosine 3′5′ monophosphate-dependent protein kinase activity in rat stomach carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine. Cancer Res. 45: 4763–4767.